General Information


DRACP ID  DRACP03862

Peptide Name  

Sequence  IIKKIIKKIIKKI

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C78H151N19O14

Absent amino acids  ACDEFGHLMNPQRSTVWY

Common amino acids  I

Mass  179342

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  7

Net charge  6

Boman Index  114

Hydrophobicity  62.31

Aliphatic Index  210

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26204061

Title  High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13881

DRACP is developed by Dr.Zheng's team.